Equipas-R is specifically designed to prevent the contraction of Rhodococcus equi infection by foals, a condition that can lead to life-long complications.

VISIT FOR 'HOW TO' GUIDES >> Equiplas-R is Plasvacc's hyperimmunised equine plasma product specifically designed to prevent the contraction of Rhodococcus equi infection by foals. Rich in specific anti-Rhodococcus gamma globulins, Equiplas-R is collected from specially hyperimmunised donor horses that reside at the Plasvacc plasma production facility, the only facility of its kind in Australia. Rhodococcus equi is a soil/dust borne organism that is inhaled into the lungs during hot, dry, dusty conditions.  R Equi infection, or "Rattles" as it is more commonly known, causes a severe pneumonia and can result in long-term debility or death.  Even if successfully treated, the ramifications of this disease can be ongoing. Despite the substantial treatment costs, a horse that has recovered from this condition may never reach its full athletic potential. Usually contracted at birth, or soon thereafter, Rhodococcus equi can be prevented through the administration of Equiplas-R to every foal in a group at birth, and again three weeks later.  Considering the significant impact of this disease on the long-term health and condition of the animal, the importance of administering Equiplas R as a preventative aid cannot be underestimated. Equiplas-R is now registered with the Australia Pesticides and Veterinary Medicines Authority. EquiplasR